Burjeel Holdings files for $750M IPO, the largest UAE healthcare listing since NMC Health in 2012

Burjeel Holdings, founded by Dr. Shamsheer Vayalil, is seeking to raise $750 million through an IPO on the Abu Dhabi Securities Exchange (ADX), according to filings reviewed by Gulf Business. The listing would be the largest UAE healthcare IPO since NMC Health raised $877 million on the London Stock Exchange in 2012, and the first pure-play hospital operator to trade on ADX.

The offering arrives during a sustained run of Abu Dhabi listings. ADX has attracted a string of debuts since late 2021, including ADNOC Drilling, Fertiglobe, and Abu Dhabi Ports. Burjeel would give institutional investors direct exposure to a sector that has been difficult to access through Gulf capital markets.

What Burjeel brings to the public market

Burjeel operates 40+ facilities across the UAE and Oman, from tertiary hospitals to medical centres and pharmacies. Its flagship, Burjeel Medical City in Abu Dhabi, is a 350-bed tertiary hospital licensed by the Department of Health Abu Dhabi (DOH) for complex procedures including oncology, organ transplant, and cardiac surgery. The group employs more than 4,500 healthcare professionals.

Revenue is concentrated in Abu Dhabi, where mandatory health insurance under the Daman scheme and a large expatriate population have driven consistent volume growth. The DOH reported 33.6 million outpatient visits across the emirate in 2021, a figure that has grown at roughly 6% annually since 2018. Burjeel captures a meaningful share of that volume through its network of primary, secondary, and tertiary facilities.

The company also operates a medical tourism arm that draws patients from East Africa, South Asia, and the wider GCC. Abu Dhabi's strategy to become a regional healthcare destination, laid out in the DOH's Abu Dhabi Healthcare Strategic Plan 2021–2025, has increased referral volume for operators with tertiary-level capabilities.

Market context and competitive positioning

The UAE private healthcare market was valued at approximately AED 52 billion in 2021, according to Alpen Capital. Growth has been driven by population expansion, rising chronic disease prevalence, government mandates requiring private insurance for all residents, and an expanding expatriate workforce.

Burjeel's listing would place it alongside publicly traded peers including Mediclinic Middle East (part of London-listed Mediclinic International) and Aster DM Healthcare (listed on India's BSE). The UAE market also includes Pure Health, the Abu Dhabi government-backed holding company that has been acquiring assets at pace, and Fakeeh Care Group, which explored its own ADX listing earlier in 2022.

For CFOs at competing hospital groups, the IPO prospectus will disclose granular financials, occupancy rates, and revenue per bed that have been opaque in the private market. Those benchmarks will become public reference points for the first time.

What operators should watch

The pricing and reception of the Burjeel IPO will signal how public investors value UAE healthcare assets at a time when the sector is consolidating. Four factors will shape the outcome:

• Insurance reimbursement trends: the DOH's ongoing review of the unified healthcare coverage model could affect margins for operators dependent on government-backed insurance pools
• Staffing costs: healthcare salary inflation across the UAE averaged 8–12% in 2022, driven by global competition for nurses and specialists
• Capital deployment: how Burjeel uses IPO proceeds (debt reduction, new facilities, or regional expansion) will indicate where management sees the highest-return opportunities
• Valuation multiples: the listing price will establish a benchmark EV/EBITDA for private UAE hospital transactions going forward

Burjeel has appointed First Abu Dhabi Bank (FAB), Goldman Sachs, and Morgan Stanley to manage the offering. A prospectus is expected in the coming weeks, with listing targeted for Q4 2022. The Securities and Commodities Authority (SCA) must approve the final offering terms before shares begin trading.